leisure time -WSS

leisure time

author：knowledge 2025-08-29 19:59:02 - browse：895

Allergan, Dom Smith/STAT

It wasn’t supposed to work out this way for Brent Saunders.

Four years ago, Saunders was the whiz kid of the pharmaceutical set. At 44, he had created a large pharmaceutical firm, then called Actavis, almost by force of will after engineering more than $100 billion in deals in a two-year span. Then he had swooped in to rescue Botox maker Allergan from the nefarious claws of Valeant Pharmaceuticals, an asset-stripping drug company loved by many on Wall Street but no one with a conscience.

As CEO, he paired his dealmaking with a boyish charm and a willingness to take on big issues that made him seem like a potential spokesman for the whole industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Three trends to watch in biotech in 2024

WSS

Christmas in the PICU brings some surprising joy

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Virtual care provider acquires bankrupt Pear's prescription apps

U.S. death rates show how politics are affecting public health

Hospitals owned by private equity see complications spike 25%

Achieving telehealth equity for people with hearing loss

entertainment

leisure time

hotspot

Heart attack and stroke risk calculators need revising

Why some fertility treatments produce more boy babies

Alkermes shareholders re

Guardant Health colon cancer test endorsed by FDA advisory panel

Apple is now the first public company to be valued at $3 trillion

Guardant Health colon cancer test endorsed by FDA advisory panel

Novavax promises a turnaround & Lilly roils the obesity market

Asahi Kasei to buy Calliditas, picking up kidney disease drug

As demand for Covid shots wanes, Moderna seeks its next success

SNAP should offer more nutrition education

knowledge

CRISPR gene editing developments we’re watching in 2024

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Medicare drug price negotiation hasn't dried up venture capital

Medical students need to learn the potent medicine of empathy

Beyond aggravation: Constipation is an American epidemic

How to keep neuroscience’s past racism from being its future

Wikipedia

hotspot

hotspot

leisure time